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Introduction
Children were among several high-risk groups who received priority vaccinations during the 
2009–2010 H1N1 pandemic, but as a group, their rates of vaccination in the U.S. during 
H1N1 barely hovered above 40% (CDC, 2011). While these rates are much greater than the 
typical 27% vaccination rate for children during seasonal flu, the rate is low for a group 
designated high risk. In past flu seasons, traditional “high risk” groups such as senior 
citizens have been vaccinated at rates of nearly 70% (MMWR, 2010). Given the heavy 
media coverage of H1N1, the increased risk children faced from the disease, their designated 
priority status, the availability of free H1N1 vaccine at most health departments, and the 
emphasis by federal flu planners on children as potential vectors of disease in a pandemic, 
the low rate of vaccination among children is alarming and deserves special scrutiny.
Parents ultimately determine whether children will receive a flu vaccination. To better 
understand parental decision-making about vaccines and effectively utilize the lessons of 
H1N1 in future, more serious pandemics, we conducted a nationwide survey of 684 parents 
at the height of the H1N1 pandemic. Here we report factors that influenced parental 
acceptance of the H1N1 vaccine and discuss implications for improving vaccine uptake for 
children in the future.
Research on parental acceptance of vaccines has focused on three primary issues and/or 
types of vaccines: 1) childhood immunizations, especially perceived vaccine risks, such as 
parental concerns about autism; 2) vaccination against human papillomavirus (HPV); and 3) 
influenza vaccinations, both seasonal – and in a handful of studies – H1N1. Although each 
vaccine issue has accompanying complications that do not permit exact comparisons (e.g. 
school mandates regarding routine MMR immunization or parental attitudes about sexual 
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In their review article advising physicians how to communicate with vaccine-hesitant 
parents, Healy and Pickering (2011) report that at least 28% of parents have been hesitant to 
vaccinate at some time. They cite three consistent reasons for vaccine refusal: fears about 
vaccine safety, concerns that vaccines may transmit the disease they are intended to 
immunize against, and the idea that contracting a disease and building “natural” immunity is 
preferable. Bhat-Schelbert et al. (2012) found in a series of focus groups with families and 
healthcare providers that fear, misinformation and mistrust, amplified by the media, were 
significant reasons for not vaccinating. However, they also found vaccination was more 
readily accepted if the disease was better understood, if a trusted person recommended 
vaccination, or if barriers such as inconvenience could be overcome. In qualitative studies in 
the UK, Leask et al. (2006) and Poltorak et al. (2005) found factors such as attitudes toward 
government and the pharmaceutical industry, past personal experiences, and trust in 
healthcare providers to be as important as the individual child’s health in determining 
parental acceptance of vaccine. Poltorak described a complex web of personal, social and 
media influences. Hobson-West (2003) argued that benefits and risks to the community, 
rather than to the individual child, would be most effective in persuading parents to 
vaccinate. Spier’s historical review (2001) of the anti-vaccination movement cited a primal 
human aversion to disturbing the status quo, which heightens the perceived risk of 
introducing a vaccine into a child’s body versus the risk of doing nothing (i.e. the risk of the 
disease).
Frew et al. (2011) surveyed 223 African American and Hispanic parents during H1N1 and 
found 41% had already vaccinated their children for seasonal flu, or intended to, and 36% 
for H1N1. Factors most associated with acceptance of the vaccine were perceived 
susceptibility of the child to H1N1, concern about the impact of H1N1 in the community, 
concern about H1N1 relative to other diseases, perception that vaccination was more 
effective than other methods of mitigation such as hand-washing, and finally, lack of 
insurance. The authors did not find demographic factors such as race, income and education 
level to be significant, and while perceived concern about vaccine safety was negatively 
associated with vaccine acceptance, safety concerns were not a significant reason for 
vaccine refusal in the sample.
Our study extends these findings about parental vaccine acceptance by examining the issue 
during the more urgent environment of a pandemic, and evaluating them through the lens of 
the Health Belief Model, or HBM (Janz & Becker, 1984; Mattson, 1999). For more than 60 
years the HBM has been successfully used to examine factors explaining why individuals 
might decline preventive public health care or screenings, especially when offered at no 
monetary cost. The HBM considers how individual behavior is affected by the following 
variables: demographics, perceived risk of disease (severity and susceptibility), perceived 
benefits of mitigating behaviors versus perceived barriers or costs, perceived self-efficacy 
(ability to perform or access mitigation steps), and cues to action, which might include 
environmental prompts such as media messages, observation of role models, conversations 
with friends or family, reminders from healthcare providers, etc.
Our research questions looked separately at each variable in the HBM to ask: “Is this 
individual variable a significant predictor of a parent’s behavioral intention to vaccinate a 
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child?” Our final research question was “What is the relationship or interaction between all 
of the variables in the model in predicting a parent’s behavioral intention to vaccinate a 
child?”
We confirm some associations found in previous studies, but also add a detailed 
examination of “cues to action” as a key determinant in behavioral intention. Using the 
HBM framework, we propose a model to explain parental decision-making related to the 
H1N1 vaccine and offer suggestions for practical application of the results.
Methods
From January 22, 2010 to February 1, 2010, we surveyed a nationally representative, 
random sample of 2,042 adults in the US, including oversamples of African Americans and 
Hispanics. About 40% of respondents were White Non-Hispanic with remaining sample 
evenly split between Black Non-Hispanics and Hispanics. There were roughly equal number 
of males and females (47%, 53%, respectively). The respondents were between 18 and 95 
years old. The survey was approved by the researchers’ Institutional Review Boards (IRBs) 
and conducted online by Knowledge Networks. The sample was drawn from its panel of 
approximately 40,000 individuals recruited by random-digit-dialing, and included 
households without traditional Internet access. All analyses were weighted to be 
demographically representative of the US population as reported by the January 2010 
Current Population Survey (CPS). Of this sample, 684 were parents of children under 18 
years old.
In examining vaccine behavior and behavioral intention to get vaccinated, we divided 
respondents into two groups: those who vaccinated at least one of their children, and those 
who vaccinated none.
The survey instrument was designed by nationally recognized experts in health 
communication and vaccine behavior on the research team, and pilot tested by Knowledge 
Networks before deployment. The survey described H1N1 as “the current influenza 
outbreak” and used the term “swine flu” rather than H1N1, indicating they were in fact 
interchangeable terms. The survey included 80 questions and 350 individual items covering 
a variety of issues important to public health practitioners responding in real time to the 
unfolding pandemic. Of these survey items, 26 corresponded to elements of the Health 
Belief Model (HBM), including perceived susceptibility to H1N1 (“How likely do you think 
it is that one of your children under 18 will become ill with swine flu?”); perceived severity 
of H1N (“If one of your children under 18 became ill with swine flu, how severe do you 
think the illness will be?”); perceived costs and benefits of receiving the H1N1 vaccine 
(including monetary costs; inconvenience; concerns about vaccine risks and side effects; and 
efficacy of vaccine versus other mitigations, (see Table 2 for complete list); and perceived 
self-efficacy (confidence they could get the H1N1 vaccine). Cues to action included levels 
of worry; perception (whether accurate or not) of being in a vaccine priority group; 
influence of friends, family, media coverage, and public health communication (e.g. “How 
influential was [your best friend/your doctor/TV news] to your decision about the swine flu 
vaccine?”); and influence of President Obama’s decision to vaccinate his daughters (e.g. 
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“Knowing the President had his daughters vaccinated would increase my willingness to have 
my children vaccinated”). The first stage of our analysis examined descriptive statistics to 
look for differences between groups. The second step of analysis was a k-cluster analysis of 
the 12-item list of possible costs and benefits associated with the H1N1 vaccine, to identify 
homogeneous groups of respondents. The number of clusters was chosen based on 
interpretability and differences among the clusters and three clusters emerged (Kaufman & 
Rousseeuw, 1990). Missing data for these variables ranged from 2% to 3% and were 
imputed using the Expectation- Maximization Algorithm (Dempster, Laird, & Rubin, 1977).
The third and final stage of our analysis tested the Health Belief Model using structural 
equation modeling (SEM), controlling for demographics such as race, gender, age, income, 
education and health insurance coverage (see, Figure 2). The model was estimated using 
mean- and variance-adjusted weighted least squares (WLSMV), which does not assume 
normality. Since the model χ2 is sensitive to the sample size in SEM, three fit indexes were 
used: 1) the comparative fit index, or CFI (Bentler, 1990); 2) the root mean square error of 
approximation, or RMSEA (Steiger & Lind, 1980); and 3) weighted root mean square 
residual or WRMR ((Muthén & Muthén, 2010). A model is considered good if CFI ≥ 0.95, 
RMSEA ≤ 0.06, and WRMR ≤ 0.90.
Results
Overall in our sample of parents with children under age 18 (n=684), 62% vaccinated none 
of their children, 31% vaccinated all, and 7% vaccinated some. Parents of children with 
unspecified “underlying health conditions” were more likely to get some or all of their 
children vaccinated (49% versus 35% of those whose children had no health conditions, p 
= .009).
Some of our data confirmed trends seen in earlier studies of vaccine behavior (see e.g. Bhat-
Schelbert et al., 2012; Leask et al., 2006; Poltorak et al., 2005, and Frew et al., 2011). In 
descriptive analysis, there was no significant difference between people with and without 
insurance in accepting vaccines for their children (42% vs. 37%, p = .293). Additionally, 
there were strong relationships between uptake and knowledge, and between uptake and 
media consumption about H1N1; medical practitioners were influential, particularly to 
younger parents. Across the entire sample, parents’ education levels were important: 
participants with less than a high school education were significantly more likely to 
vaccinate some or all children than participants with some college or more education (47% 
vs. 29%, p < .001).
Within the framework of the Health Belief Model (HBM), we used structural equation 
modeling to examine the following predictors: demographics, perceived susceptibility to 
H1N1 and perceived severity of the virus, perceived costs and benefits of vaccination, cues 
to action, and self-efficacy. There was a significant difference between the observed and the 
model covariance matrices, χ2 (55) = 175.52. However, there was a “good” fit, CFI = .950, 
RMSEA = .057, WRMR = .832 (Figure 2). The factor loadings of cues to action ranged 
from .49 to .77. The HBM explained 38% of the variability in parental acceptance of the 
H1N1 vaccine, with “cues to action” being the most significant predictor associated with 
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parental acceptance, and two other HBM variables, costs & benefits and self-efficacy, also 
playing a role. There was moderate correlation among perceived susceptibility, perceived 
severity, and cues to action (.28 to .33). However, the correlations of these variables to costs 
and benefits were low (.01 to .11).
Because race was significant in overall rates of parental acceptance, we singled it out for 
special consideration as a predictor of response to other variables (Kumar, Quinn, Kim, 
Daniel, & Freimuth, 2012). After adjusting for other demographic variables in the SEM 
analysis, there were significant differences in perceived susceptibility, perceived severity, 
and cues-to-action items among races: Hispanics had the highest perceived susceptibility, 
perceived severity, and stronger responses to all cues-to-action items (β = .36) compared to 
Whites. African Americans were significantly more likely than Whites to be affected by 
cues to action (β = .13). There was no significant difference between African Americans and 
Whites in perceived susceptibility and severity regarding H1N1, but Hispanics had higher 
perceptions of both perceived severity and susceptibility compared to Whites. Only about 
8% of perceived susceptibility was explained by race and demographic variables, while 
nearly 20% of perceived severity was explained by the same variables. However, in the 
overall model, these measures of perceived risk were not significant predictors of vaccine 
acceptance.
Moving to perceived costs and benefits of the H1N1 vaccine, our analysis found African 
Americans and Hispanics were about 1.2 times more concerned than Whites about both 
vaccine risks and about adverse effects of the H1N1 virus (e.g. including missing work and 
spreading the disease to others). In general, the greater the perceived “cost” of the H1N1 
vaccine (including perceived vaccine risks, perceived limited efficacy, or financial cost), the 
less likely parents were to vaccinate any of their children; as perceived costs outweighed 
benefits, parents were only 77% as likely to get their kids vaccinated.
In some health behaviors, perceived costs and benefits may be unambiguous, (for example, 
smoking cessation). However, the perceived costs and benefits of accepting a vaccine are 
somewhat more nuanced and conflicting because of widespread concerns about vaccine 
safety that compete with concerns about disease. To capture this complexity within our path 
model, we conducted a cluster analysis of the cost-benefit items, discovering three distinct 
cost-benefit clusters, which we then used in the path model: the “Worried” (worried about 
H1N1, worried about the vaccine – “high”) comprised 41% of participants; the 
“Unconcerned” (worried about neither disease nor vaccine – “low”) represented 28%; and 
the “Vaccine-Averse” (worried about the vaccine but not about the disease – “medium”) 
made up 31%. We expected to see a fourth group, worried about the risk of H1N1 but not 
worried about the risk of the vaccine, however, there was no cluster of respondents matching 
this profile. There were significant differences between the clusters on all the cost-benefit 
items, and most of the differences had a large effect size (Table 2 & Figure 1). Cluster 
groups were significantly likely to predict vaccine uptake, with the Worried 73% more 
likely to get their child vaccinated.
Cues to action (including worry; perceived membership in a vaccine priority group; and the 
influence of friends, family, media coverage, public health communication, and President 
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Obama’s decision to vaccinate his daughters) were significant predictors of vaccine uptake, 
even when controlled for demographics and political affiliation. The factor loadings of cues 
to action ranged from .48 to .75. Respondents got children vaccinated at a 1.4 times higher 
rate for every standard deviation increase in the level of impact of cues to action.
The costs-and-benefits cluster and cues to action explained about 30% of variability in self-
efficacy. There was a significant positive prediction of self-efficacy by cues to action, and a 
significant negative prediction of self-efficacy by those in the “Worried” cost-benefit 
cluster. Parents were 1.3 times more likely than others to get their children vaccinated for 
every standard deviation increase in self-efficacy.
Discussion
Our survey was created rapidly, in response to the information needs of public health 
practitioners during the unfolding H1N1 pandemic, rather than as a purely theoretic test of 
the Health Belief Model. Although our measures are typical of those often used in the HBM 
(for examples, see Brewer et al., 2007; Brewer & Fazekas, 2007; Janz & Becker, 1984; 
McCaul, Branstetter, Schroeder, & Glasgow, 1996; Rimal, 2001; Witte & Allen, 2000), 
some measures are less robust than others, and our analysis does not attempt to add to the 
literature on the HBM. Rather, we use it as a framework that may possibly explain parental 
behavior, and could be used to help public health officials more effectively segment and 
communicate with this audience.
When our initial analysis of data revealed, somewhat counter-intuitively, that higher levels 
of risk perception about H1N1 were not associated with increased parental acceptance of the 
vaccine, we searched for clues that could predict what separated parents who opted for the 
vaccine from those who did not. A conceptualization of the HBM in which cues to action 
take a central role proved to be a very good fit, explaining much of the difference between 
the two groups.
Our key finding was that cues to action at all levels, from intrapersonal all the way to mass 
media, may be far more important in vaccine decision-making than perceived risk. In 
practice, this means scary messages about the impact of H1N1 may be ineffective in 
motivating people to action. What we found instead (and other recent studies have 
confirmed, see for example, Mileti, et al., 2011), was the significant effect of affirming 
messages and role models, either within an individual’s social network or in a position of 
authority or celebrity, such as the Obamas’ modeling of vaccine acceptance for their 
daughters. This indicates an important role for social media; for news coverage that may 
include personal testimonials, especially from community opinion leaders; or perhaps 
visuals depicting the accessibility and popularity of flu clinics. It also may inform 
practitioner-patient communication by focusing the conversation away from persuading 
parents of the dangers of a disease and focusing instead on social norms related to 
vaccination, and possibly even on the doctor’s own decision-making process with regard to 
child vaccination.
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Perceived risk as measured by traditional items asking about susceptibility and severity was 
not significant, but risk did appear to matter as measured indirectly in the cost-benefit index 
(where one perceived vaccination “benefit” -- not missing work because of a sick child -- 
may reflect perceived “risk” of the disease’s consequences). The index, of course, contained 
items not just dealing with the risk of H1N1, but perceived risk of vaccine acceptance; it was 
the perception that disease risk outweighed vaccine risk that was significant. This indicates 
traditional measures of risk may not be capturing the cost-benefit analysis inherent in 
vaccine decision making; when parents perceive risks of both the disease and the vaccine, 
the decision-making process is no doubt different than for a risk perceived as unambiguous. 
(Indeed, we initially planned to subtract perceived costs from perceived benefits, as is 
customary in the HBM, until our examination of the data indicated that for many 
respondents, the calculation was not as straightforward as it might be for other health issues. 
We ultimately chose to create an index as a more robust way of capturing this complexity, 
then used cluster analysis to identify patterns among respondents).
One possible approach suggested by our findings is that rather than simply emphasizing the 
risk of the disease, communicators may need to acknowledge potential perceived risks of the 
vaccine and emphasize the greater comparative risk of the disease itself. Alternatively, 
perceived risk of the disease may be unimportant as a motivator; rather, the important thing 
may be overcoming perceived risk of vaccine. It is also possible risk issues should take a 
backseat to stronger, better motivators – as indicated by our overall findings about the 
effects of cues to action.
The importance of emphasizing these relative risks may also depend on the target group. 
The cluster analysis provides important insight into the psychology behind vaccine decision-
making. Not surprisingly, the Worried are most likely to accept the vaccine for their child. 
Our data showed they worried about both the disease and the vaccine, but it appears as if the 
vaccine was ultimately favored in the Worried’s cost-benefit analysis. Exactly what led to 
that decision is not apparent in the data, however, cues to action appear to have been an 
important prompt for this group, indicating that someone ambivalent about relative risks and 
benefits can be influenced by cues from the media and important others. Personal 
testimonials and social media, in addition to mass media, may be an important channel for 
these cues.
The Unconcerned may not be influenced by the same cues to action; they are not worried 
and do not need reassurance. It is unclear from our results whether it would be possible to 
increase risk perception of the disease among this group, and whether increased disease risk 
perception alone would be effective in achieving vaccine acceptance, given that our model 
showed risk perception alone was not significantly associated with uptake. Future research 
should investigate other potential cues to action for this group, including the influence of 
friends, family, health professionals and the media.
Those who we classified as Vaccine-Averse might be responsive to risk information on 
either side of the cost-benefit equation. On the other hand, such information might require 
them to admit they had been wrong about vaccines, or could potentially cause them to 
become more entrenched in their views. Although this group of parents is a critical one to 
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reach, it may make sense for communicators and public health officials to focus on the more 
winnable battle of persuading approximately two-thirds of people who are either Worried or 
Unconcerned to choose vaccination for their children. Such a strategy would help establish 
parental acceptance of vaccine as a social norm in the wider community, perhaps leading to 
more success when focusing in the future on the Vaccine-Averse.
Self-efficacy, or the confidence an individual had that they could get the H1N1 vaccine, 
appeared to work in our model. However, as a single item measure it provides little data for 
interpretation and may be confounded by concerns about availability or even attitudes 
toward the vaccine. Greater understanding of the components of this variable is needed to 
help understand why it boosted vaccine rates so significantly.
Initial descriptive data showed some significant demographic differences, and some of them 
were, indeed, puzzling, such as the higher vaccination rates among parents with high school 
education only versus those with some college. However, when examining each 
demographic individually (while controlling for others), none of the demographics, 
including race or education, continued to play a large role. This should come as good news 
to practitioners in the field, since demographics cannot be altered and the behaviors and 
traits associated with them can be extremely difficult to change. However, messages, cues 
and perceptions are all imminently changeable with the right approach, and may still need to 
be tailored to the racial, ethnic or cultural norms of those groups practitioners are trying to 
reach.
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Cluster analysis of cost- benefit items
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Table 2






(N = 277) η2
Want to build natural immunities 1.63 (.77) 2.92 (.89) 2.96 (1.02) .30
I am worried about side effects of the vaccine 1.59 (.75) 2.76 (.91) 3.66 (.63) .55
I believe the vaccine is ineffective 1.35 (.61) 1.93 (.80) 2.99 (.87) .44
I don’t want to miss work 1.33 (.68) 2.09 (1.09) 2.16 (1.18) .11
I am concerned vaccine is not safe 1.37 (.56) 2.38 (.91) 3.64 (.64) .63
I don’t want to spread the flu to others 2.09 (1.10) 3.56 (.68) 3.15 (1.02) .27
Flu shots are effective (reverse coded) 2.16 (.80) 1.94 (.58) 2.47 (.81) .08
Newly developed flu vaccine is safe (reverse coded) 2.23 (.75) 2.06 (.57) 2.77 (.76) .17
Vaccine is riskier than disease itself 1.81 (.68) 1.94 (.65) 2.68 (.78) .24
Most vaccines are not safe 1.82 (.67) 1.84 (.54) 2.50 (.75) .19
Children are at greater risk from vaccine than disease 1.80 (.65) 1.94 (.65) 2.54 (.77) .18
I will never get another flu shot because of previous negative experience 1.64 (.69) 1.61 (.69) 2.01 (.90) .06
Mean 1.73 (.29) 2.25 (.24) 2.79 (.31) .70
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